157 related articles for article (PubMed ID: 6494025)
1. Vasopressin analgesia: specificity of action and non-opioid effects.
Kordower JH; Bodnar RJ
Peptides; 1984; 5(4):747-56. PubMed ID: 6494025
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of dPTyr(Me)AVP, a vasopressin antagonist, upon foot shock analgesia.
Kordower JH; Bodnar RJ
Int J Neurosci; 1985 Dec; 28(3-4):269-78. PubMed ID: 3005187
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate.
Bodnar RJ; Truesdell LS; Nilaver G
Peptides; 1985; 6(4):621-6. PubMed ID: 4070021
[TBL] [Abstract][Full Text] [Related]
4. Central injections of arginine vasopressin prolong extinction of active avoidance.
Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic icv infusion of vasopressin on sleep-waking cycle of rats.
Arnauld E; Bibene V; Meynard J; Rodriguez F; Vincent JD
Am J Physiol; 1989 Mar; 256(3 Pt 2):R674-84. PubMed ID: 2923256
[TBL] [Abstract][Full Text] [Related]
6. Role of endogenous vasopressin in development of gastric ulcer induced by restraint and water immersion.
Honda K; Fukuda S; Ishikawa SE; Kuzuya T; Saito T
Am J Physiol; 1994 May; 266(5 Pt 2):R1448-53. PubMed ID: 8203619
[TBL] [Abstract][Full Text] [Related]
7. Central antinociceptive effects of lysine-vasopressin and an analogue.
Kordower JH; Sikorszky V; Bodnar RJ
Peptides; 1982; 3(4):613-7. PubMed ID: 7134029
[TBL] [Abstract][Full Text] [Related]
8. Chronic intracerebral infusions of vasopressin and vasopressin antagonist modulate behavioral effects of interleukin-1 in rat.
Bluthé RM; Dantzer R
Brain Res Bull; 1992 Dec; 29(6):897-900. PubMed ID: 1473021
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
Lebrun C; Le Moal M; Koob GF; Bloom FE
Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
[TBL] [Abstract][Full Text] [Related]
10. Enhanced pressor responses to ICV vasopressin after pretreatment with oxytocin.
Poulin P; Komulainen A; Takahashi Y; Pittman QJ
Am J Physiol; 1994 Feb; 266(2 Pt 2):R592-8. PubMed ID: 8141420
[TBL] [Abstract][Full Text] [Related]
11. Specificity of aversive stimulus properties of vasopressin.
Bluthé RM; Dantzer R; Mormède P; Le Moal M
Psychopharmacology (Berl); 1985; 87(2):238-41. PubMed ID: 3931152
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.
Diamant M; De Wied D
Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886
[TBL] [Abstract][Full Text] [Related]
13. Arginine vasopressin and a vasopressin antagonist peptide: opposite effects on extinction of active avoidance in rats.
Koob GF; Le Moal M; Gaffori O; Manning M; Sawyer WH; Rivier J; Bloom FE
Regul Pept; 1981 Jun; 2(3):153-63. PubMed ID: 7255768
[TBL] [Abstract][Full Text] [Related]
14. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
Federico P; Veale WL; Pittman QJ
Am J Physiol; 1992 May; 262(5 Pt 2):R901-8. PubMed ID: 1534208
[TBL] [Abstract][Full Text] [Related]
15. Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats.
Maione S; Vitagliano S; Berrino L; Lampa E; Rossi F
Neuropharmacology; 1992 Apr; 31(4):403-7. PubMed ID: 1355901
[TBL] [Abstract][Full Text] [Related]
16. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
Croiset G; De Wied D
Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin antagonists block peripheral as well as central vasopressin receptors.
De Wied D; Gaffori O; Van Ree JM; De Jong W
Pharmacol Biochem Behav; 1984 Sep; 21(3):393-400. PubMed ID: 6093152
[TBL] [Abstract][Full Text] [Related]
18. Do the circulating neurohypophysial hormones affect basal or stress induced prolactin (PRL) release in male rats?
Jurcovicová J; Dobrakovová M; Oprsalová Z; Jezová D; Makara GB; Kvetnanský R
Endocr Regul; 1991 Sep; 25(3):159-63. PubMed ID: 1764605
[TBL] [Abstract][Full Text] [Related]
19. A comparison of grooming behavior potencies of neurohypophyseal nonapeptides.
Caldwell JD; Drago F; Prange AJ; Pedersen CA
Regul Pept; 1986 May; 14(3):261-71. PubMed ID: 3014615
[TBL] [Abstract][Full Text] [Related]
20. EEG effects of subcutaneous and intracerebroventricular injections of arginine vasopressin in the rat.
Ehlers CL; Reed TK; Wang M; Lebrun CJ; Koob GF
Psychopharmacology (Berl); 1985; 87(4):430-3. PubMed ID: 3936102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
